1. Home
  2. HALO vs LPX Comparison

HALO vs LPX Comparison

Compare HALO & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LPX
  • Stock Information
  • Founded
  • HALO 1998
  • LPX 1973
  • Country
  • HALO United States
  • LPX United States
  • Employees
  • HALO N/A
  • LPX N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LPX Forest Products
  • Sector
  • HALO Health Care
  • LPX Basic Materials
  • Exchange
  • HALO Nasdaq
  • LPX Nasdaq
  • Market Cap
  • HALO 7.4B
  • LPX 6.2B
  • IPO Year
  • HALO N/A
  • LPX N/A
  • Fundamental
  • Price
  • HALO $56.07
  • LPX $89.99
  • Analyst Decision
  • HALO Buy
  • LPX Buy
  • Analyst Count
  • HALO 9
  • LPX 8
  • Target Price
  • HALO $63.56
  • LPX $108.13
  • AVG Volume (30 Days)
  • HALO 3.5M
  • LPX 851.0K
  • Earning Date
  • HALO 05-06-2025
  • LPX 05-06-2025
  • Dividend Yield
  • HALO N/A
  • LPX 1.24%
  • EPS Growth
  • HALO 55.40
  • LPX 56.47
  • EPS
  • HALO 3.76
  • LPX 5.71
  • Revenue
  • HALO $1,084,306,000.00
  • LPX $2,941,000,000.00
  • Revenue This Year
  • HALO $25.77
  • LPX $0.31
  • Revenue Next Year
  • HALO $18.01
  • LPX $7.25
  • P/E Ratio
  • HALO $14.92
  • LPX $15.77
  • Revenue Growth
  • HALO 25.64
  • LPX 8.09
  • 52 Week Low
  • HALO $42.01
  • LPX $78.82
  • 52 Week High
  • HALO $70.51
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • HALO 48.34
  • LPX 47.46
  • Support Level
  • HALO $54.00
  • LPX $89.98
  • Resistance Level
  • HALO $55.25
  • LPX $94.87
  • Average True Range (ATR)
  • HALO 2.53
  • LPX 2.19
  • MACD
  • HALO 0.14
  • LPX -0.33
  • Stochastic Oscillator
  • HALO 42.01
  • LPX 7.59

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: